Rockefeller Capital Management L.P. Aerie Pharmaceuticals Inc Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$4.95 - $9.16 $1,425 - $2,638	288 New	288 $2,000
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $4,598 - $8,731	-655 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$15.16 - $18.97 $9,929 - $12,425	655 New	655 $10,000
Q4 2020 Feb 12, 2021	SELL	$9.12 - $14.49 $4,167 - $6,621	-457 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$10.46 - $14.46 $1,746 - $2,414	167 Added 57.59%	457 $5,000

Q2 2020 Aug 12, 2020	SELL	$12.0 - $16.13 $1,656 - $2,225	-138 Reduced 32.24%	290 $4,000
Q1 2020 May 12, 2020	BUY	$11.84 - $25.52 $5,067 - $10,922	428 New	428 $6,000
Q2 2019 Aug 09, 2019	SELL	$28.97 - $48.21 $579 - $964	-20 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$36.32 - $49.25 $726 - $985	20 New	20 $1,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.